BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
23 results:

  • 1. Prediction of EVT6-NTRK3-Dependent Papillary thyroid cancer Using Minor Expression Profile.
    Kechin AA; Ivanov AA; Kel AE; Kalmykov AS; Oskorbin IP; Boyarskikh UA; Kharpov EA; Bakharev SY; Oskina NA; Samuilenkova OV; Vikhlyanov IV; Kushlinskii NE; Filipenko ML
    Bull Exp Biol Med; 2022 Jun; 173(2):252-256. PubMed ID: 35737155
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. miR-551b is Associated with the Poor Prognosis and Malignant Development of Papillary thyroid cancer Through Regulating erbb4.
    Wang J; Liu H
    Horm Metab Res; 2022 Feb; 54(2):113-118. PubMed ID: 35130572
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
    Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
    Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
    Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
    Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lateral Lymph Node Metastases in T1a Papillary thyroid Carcinoma: Stratification by Tumor Location and Size.
    Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
    Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Robot-assisted Nipple-sparing Mastectomy With Immediate Breast Reconstruction: An initial Experience of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG).
    Ryu JM; Kim JY; Choi HJ; Ko B; Kim J; Cho J; Lee MH; Choi JE; Kim JH; Lee J; Jung SM; Shin HJ; Lee J; Park HS
    Ann Surg; 2022 May; 275(5):985-991. PubMed ID: 32941285
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and erbb4.
    Nie FR; Li QX; Wei HF; Ma Y
    Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
    You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
    J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer.
    Chen CY; Wu SM; Lin YH; Chi HC; Lin SL; Yeh CT; Chuang WY; Lin KH
    Theranostics; 2019; 9(8):2361-2379. PubMed ID: 31149049
    [No Abstract]    [Full Text] [Related]  

  • 10. Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.
    Vattai A; Akyol E; Kuhn C; Hofmann S; Heidegger H; von Koch F; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Spitzweg C; Toth B; Mahner S; Jeschke U; Ditsch N
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1637-1647. PubMed ID: 28409272
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Human epidermal growth factor receptor 4 (her4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis.
    Wang J; Yin J; Yang Q; Ding F; Chen X; Li B; Tian X
    Oncotarget; 2016 Nov; 7(47):76693-76703. PubMed ID: 27736797
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.
    Lamberts LE; de Groot DJ; Bense RD; de Vries EG; Fehrmann RS
    Oncotarget; 2015 Sep; 6(29):28164-72. PubMed ID: 26172299
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas.
    Schulten HJ; Alotibi R; Al-Ahmadi A; Ata M; Karim S; Huwait E; Gari M; Al-Ghamdi K; Al-Mashat F; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S6. PubMed ID: 25922907
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells.
    Ota I; Higashiyama S; Masui T; Yane K; Hosoi H; Matsuura N
    Oncol Rep; 2013 Oct; 30(4):1593-600. PubMed ID: 23917679
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.
    Wiseman SM; Griffith OL; Melck A; Masoudi H; Gown A; Nabi IR; Jones SJ
    Am J Surg; 2008 May; 195(5):667-73; discussion 673. PubMed ID: 18424286
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Characterization of a novel tripartite nuclear localization sequence in the EGFR family.
    Hsu SC; Hung MC
    J Biol Chem; 2007 Apr; 282(14):10432-40. PubMed ID: 17283074
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
    Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Bugis S; Filipenko D; Huntsman D; Gilks B
    Ann Surg Oncol; 2007 Feb; 14(2):719-29. PubMed ID: 17115102
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E; Calvo JC
    J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.